GRAMPIAN BIOPARTNERS
GBP was founded in March 2008 by Professor Andy Porter and Drs Keith Charlton and Gillian Broadbent. GBP is an angel investment group that specialises in seed funding early stage life-science companies. Typical investments are of the order of £50-200k. This grouping is unusual because its internationally recognised scientific team is used by other agencies and investment groups to carry out scientific due diligence prior to their investment.GBP became a Scottish co-investment partner on 1st Apr... il 2010. To date the company has made ten investments in Scotland and one in a Malaysian company looking to relocate part of its business to Scotland.The company's major commercial and science focus covers immuno-diagnostics and devices, immuno-technology, biologic drug discovery. GBP has particular expertise in the areas of antibody diagnostics and biologic therapeutics. More recently it has also made early stage assessments and investments in regenerative medicine and vaccine/drug delivery companies.
GRAMPIAN BIOPARTNERS
Industry:
Asset Management Impact Investing
Founded:
2008-03-01
Status:
Active
Technology used in webpage:
SPF LetsEncrypt Pound Sterling LiteSpeed
Similar Organizations
Azora
Azora is an investment management firm that specializes in managing real estate assets.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-03-03 | NovaBiotics | Grampian Biopartners investment in Venture Round - NovaBiotics | 3 M GBP |
| 2009-03-16 | Antoxis | Grampian Biopartners investment in Seed Round - Antoxis | 300 K GBP |
More informations about "Grampian Biopartners"
Grampian Biopartners Investor Profile: Portfolio & Exits - PitchBook
Grampian Biopartners General Information Company Description. Founded in 2008, Grampian Biopartners was an angel group based in Aberdeen, United Kingdom. The firm sought to …See details»
Grampian Biopartners - Investments, Portfolio & Company Exits
Mar 3, 2016 Grampian Biopartners has made 2 investments. Their most recent investment was on Mar 3, 2016, when NovaBiotics raised. obfuscated. obfuscated. How many investments …See details»
Grampian Biopartners Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Grampian Biopartners Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
GRAMPIAN BIOPARTNERS LIMITED overview - Find and update …
Filing history for GRAMPIAN BIOPARTNERS LIMITED (SC339134) People for GRAMPIAN BIOPARTNERS LIMITED (SC339134) More for GRAMPIAN BIOPARTNERS LIMITED …See details»
Grampian Biopartners - E2EXCHANGE
Grampian Biopartners is a angel investment group and venture capital firm that prefers to invest in companies operating in the biologic drug discovery, antibody, alternative scaffold, protein, …See details»
Grampian Biopartners - Crunchbase
Grampian Biopartners is an angel investment group that specialises in seed funding early stage life-science companies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Grampian Biopartners - Overview, News & Competitors - ZoomInfo
Grampian Biopartners. Business Services · United Kingdom · <25 Employees . Grampian Bio Partners Ltd is an angel investment group that specialises in seed funding early stage life …See details»
Grampian Biopartners - Investor Profile, Portfolio & Team - Tracxn
Grampian Biopartners - Seed & Early stage life sciences-focused VC firm funding companies in the UK. Portfolio of 5 companies. 2 investors have invested with Grampian Biopartners. Team …See details»
Grampian Biopartners - BioCentury Company Profiles - BCIQ
Grampian Biopartners - BioCentury Company Profiles for the biopharma industrySee details»
Grampian BioPartners Ltd - Latest News
Older News. NovaBiotics secures an additional £3.0 million investment from Woodford Investment Management | 3rd March 2017 Commercial Collaboration Deal for (Oral) Lynovex® | 5th …See details»
Grampian BioPartners - CB Insights
Grampian Bio-partners is a small venture capital fund founded by Andy Porter in partnership with founding scientists of Haptogen. Use the CB Insights Platform to explore Grampian …See details»
Grampian BioPartners Ltd - Latest News
Mar 22, 2011 GRAMPIAN BIOPARTNERS LTD (GBP), based in Aberdeen, was formed in 2008 by three colleagues who were the scientific founders of Haptogen, a spinout from the …See details»
GRAMPIAN BIOPARTNERS LIMITED - Companies House
GRAMPIAN BIOPARTNERS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»
Immunosolv merges with BioConsultants - Business Insider
Aug 30, 2010 Dr Ruth Murray, chief executive and co-founder of ImmunoSolv, said: "The merger with GBC, together with support through the investment funding from Grampian BioPartners …See details»
Grampian Biopartners - Updates, News, Events, Signals & Triggers
Grampian Biopartners is an angel investment group that specialises in seed funding early stage life-science companies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Grampian BioPartners Ltd - Latest News
Jun 27, 2014 The Grampian Awards for Business Excellence, which is in its 15th year and hosted by Enterprise North East Trust in 2014, commends enterprise by selecting and …See details»
Private Scottish biotechs merge and close new funding round
Sep 1, 2010 ImmunoSolv also announced the completion of a fundraising from existing investors Grampian BioPartners and the Scottish Enterprise Scottish Co-Investment Fund. In addition, …See details»
Scottish biotech companies merge - BBC News
Aug 31, 2010 The biotech firm has already secured funding from Scottish Enterprise and existing investors Grampian BioPartners. ... Andy Porter, co-founder of Grampian …See details»
Grampian Biopartners - Tech Stack, Apps, Patents & Trademarks
Grampian Biopartners is an angel investment group that specialises in seed funding early stage life-science companies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»